abstract |
The present invention provides a method for producing human immature dental pulp stem cells (hIDPSC) expressing CD44 and CD13 and lacking expression of CD146. The present invention also relates to the use of a compound of formula (I) for the manufacture of a medicament for the treatment of Parkinson's disease (PD), multiple sclerosis, amyotrophic lateral sclerosis (ALS), stroke, autoimmune encephalomyelitis, diabetic neuropathy, glaucoma neuropathy, Alzheimer's disease, A neurological disorder or condition selected from the group consisting of schizophrenia, schizophrenia, schizophrenia, schizophrenia, schizophrenia, schizophrenia, schizophrenia, schizophrenia, schizophrenia, schizophrenia, |